Find trials
Search tips

Serum Levels of Patients on Low Dose Naltrexone

Overview

About this study

The purpose of this study is to understand if low dose naltrexone can be measured in the blood, when using as a Long COVID treatment. This will be done in three ways:

1) Measure the levels of low dose naltrexone in your blood

2) Compare these levels to the dose of low dose naltrexone you are taking

3) Consider the relationship between these level in your blood and the effectiveness of the low dose naltrexone being prescribed for managing your Long COVID symptoms.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria: 

  • Eligible subjects will be identified from patients who have been seen in the PCOCC clinic who are taking LDN at the above doses.

Exclusion Criteria: 

  • Less than 18 years of age.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 2/18/2025. Questions regarding updates should be directed to the study team contact.
 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Michael Mueller, M.D.

Contact us for the latest status

Contact information:

Sara Seegmiller M.A.N., R.N.

(507) 538-7820

GIMResearchStudies@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20584003

Mayo Clinic Footer